What is The Lowdown?
Based in Manchester, United Kingdom, The Lowdown operates as a specialized healthtech platform dedicated to addressing the unique medical needs of women. The company serves as a critical bridge between patients and healthcare providers, offering a repository of reviews, information, and community-driven insights that empower users to make informed decisions about their health. By focusing on transparency and accessibility, The Lowdown has carved out a distinct market position, effectively digitizing the patient experience in a sector that has historically been underserved by traditional medical infrastructure. The platform's growth is underpinned by a commitment to evidence-based health outcomes and user-centric design, ensuring that it remains a vital resource for women navigating complex healthcare landscapes.
How much funding has The Lowdown raised?
The Lowdown has raised a total of $2.5M across 1 funding round:
Angel/Seed
$2.5M
Angel/Seed (2022): $2.5M with participation from Calm/Storm VC, Speedinvest, and Nina Capital
Key Investors in The Lowdown
Speedinvest
Speedinvest is a venture capital fund with over 1B Euro allocated for investing in pre-Seed, Seed, and early-stage tech startups across Europe, focusing on sectors including Health Bio and SaaS Infra.
Nina Capital
Nina Capital is a specialized venture capital firm focused on investing in health technology companies at the pre-seed and seed stages, providing capital to need-driven founders aiming to transform healthcare through information technology.
Calm/Storm VC
Calm/Storm VC is a European early-stage venture capital firm that focuses on health-related startups and digital health solutions, providing strategic support to founders building impactful companies.
What's next for The Lowdown?
With the successful closure of this major strategic investment, The Lowdown is poised to enter a phase of rapid scaling and product diversification. The company is expected to utilize these funds to enhance its technological infrastructure, expand its reach into new international markets, and deepen its engagement with clinical partners. As the firm transitions from its early-stage development into a more mature enterprise-level entity, the focus will likely shift toward optimizing user acquisition strategies and integrating advanced analytics to further personalize the health journey for its members. This capital infusion provides the necessary runway to solidify its leadership in the digital health space while continuing to innovate within the women's health vertical.
See full The Lowdown company page
